1696.HKEarningsprnewswire

Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning

Sentiment:Positive (70)

Summary

HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; referred to collectively with its subsidiaries as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 20, 2025 by prnewswire